{"id":"phenobutiodil","rwe":[{"pmid":"862320","year":"1977","title":"The significance of conjugated phenobutiodil (biliodyl) in the intestine in the absence of gallbladder opacification a preliminary assessment.","finding":"","journal":"Clinical radiology","studyType":"Clinical Study"}],"tags":[{"label":"phenobutiodil","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"biliodyl","offLabel":[],"synonyms":["phenobutiodil","baygnostil","biliodyl","felotrast","cholognost"],"timeline":[],"approvals":[],"brandName":"Biliodyl","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phenobutiodil","explanation":"Imagine your body's cells are like locks, and Biliodyl is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on the type of lock and the key's shape. This can help regulate various bodily functions, but more research is needed to understand how Biliodyl works and what effects it has on the body.","oneSentence":"Biliodyl is thought to work by interacting with a specific biological target, although the exact nature of this interaction is not well understood.","technicalDetail":"Biliodyl's mechanism of action is likely to involve binding to a specific protein or receptor, potentially altering its activity or expression. However, the precise molecular details of this interaction are currently unknown and require further investigation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3812","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PHENOBUTIODIL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:19:00.177755","biosimilars":[],"competitors":[],"genericName":"phenobutiodil","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"67F5J7GUUR","CHEBI":"CHEBI:135828","INN_ID":"473","UMLSCUI":"C0070568","ChEMBL_ID":"CHEMBL2104664","PUBCHEM_CID":"11127","MESH_SUPPLEMENTAL_RECORD_UI":"C008831"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1977 May","pmid":"862320","title":"The significance of conjugated phenobutiodil (biliodyl) in the intestine in the absence of gallbladder opacification a preliminary assessment.","journal":"Clinical radiology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Biliodyl, also known as PHENOBUTIODIL, is a small molecule drug in the phenobutiodil class. Its exact target and mechanism of action are unknown, and it has not been approved by the FDA for any indications. The commercial status of Biliodyl is unclear, with no information available on its patent status or generic manufacturers. Further research is needed to determine the safety and efficacy of this compound. As a result, it is not currently available for clinical use.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}